GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Medtronic PLC (HAM:2M6) » Definitions » Institutional Ownership

Medtronic (HAM:2M6) Institutional Ownership : 57.21% (As of Apr. 27, 2024)


View and export this data going back to 1980. Start your Free Trial

What is Medtronic Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Medtronic's institutional ownership is 57.21%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Medtronic's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Medtronic's Float Percentage Of Total Shares Outstanding is 99.96%.


Medtronic Institutional Ownership Historical Data

The historical data trend for Medtronic's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Medtronic Institutional Ownership Chart

Medtronic Historical Data

The historical data trend for Medtronic can be seen below:

2023-06-30 2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31
Institutional Ownership 59.96 60.17 59.57 60.86 57.57 58.03 56.97 57.32 57.31 57.21

Medtronic Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Medtronic (HAM:2M6) Business Description

Address
Lower Hatch Street, 20 On Hatch, Dublin, IRL, 2
One of the largest medical-device companies, Medtronic develops and manufactures therapeutic medical devices for chronic diseases. Its portfolio includes pacemakers, defibrillators, heart valves, stents, insulin pumps, spinal fixation devices, neurovascular products, advanced energy, and surgical tools. The company markets its products to healthcare institutions and physicians in the United States and overseas. Foreign sales account for roughly 50% of the company's total sales.

Medtronic (HAM:2M6) Headlines

No Headlines